Stories tagged 'Marie Bleakley'
3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant
$20M renewal of 4-decade-long federal grant to Hutch scientists
May 31, 2018 | By Susan Keown / Fred Hutch News Service
The National Cancer Institute has awarded Hutch with five years and nearly $20 million in funding for research to develop better therapies for people with blood cancers. The award is the latest renewal of a grant that has been funded continuously for more than 40 years.
What’s new in combatting chronic graft-vs.-host disease
Decades after the development of bone marrow transplant, researchers are making headway against one of its most common and deadly side effects
April 2, 2018 | By Rachel Tompa / Fred Hutch News Service
Up to 40% of transplant recipients develop chronic graft-vs.-host disease, which can last for years. But chronic GVHD is treatable, and new therapies and preventive measures are arriving and being tested in trials.
An opening night for heroes
Cancer survivor Rose Ibarra to be honored by Fred Hutch and Mariners at Safeco Field
March 29, 2018 | By Sabin Russell / Fred Hutch News Service
A two-time survivor of acute lymphoblastic leukemia, Rose Ibarra of West Seattle is the first of nine “Hutch Heroes” to be honored by the Mariners and Fred Hutch during Thursday home games this season.
Science without borders
At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases
Oct. 16, 2017 | By Mary Engel / Fred Hutch Research Center
Fred Hutch, like other major U.S. cancer research centers, attracts top scientists from around the world working to cure cancer, HIV and other diseases
Tags: Aude Chapuis, Basic Sciences, blood cancer, bone marrow transplantation, brain development, Cameron Turtle, cancer, Cancer etiology - prevention - outcomes, cancer research, Chu Chen, Clinical Research, developmental biology, diversity, Hans-Peter Kiem, Harmit Malik, head neck cancers, hiv, Hutch United, immigrants, immunotherapy, immunotherapy research, Jihong Bai, Jonathan Bricker, Marie Bleakley, Mazyar Shadman, Michael Boeckh, Molecular basis of cancer , neurology, Paul Edlefsen, postdoctoral fellow, Public Health Sciences, Rainer Storb, Stanley R Riddell, Tobacco & Health Behavior Science Research Group, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viral cancers
Good News at Fred Hutch
Celebrating faculty and staff achievements
April 6, 2017
Dr. Marie Bleakley receives innovator award for new leukemia immunotherapies; Dr. Anthony Rongvaux receives grant from Lupus Research Alliance; Drs. Benjamin Greer, Wui-Jin Koh win NCCN award.
'Back to normal life'
Sorting stem cells before transplant helps lower the risk of graft-vs.-host disease, researcher reports
Dec. 5, 2016 | By Bill Briggs / Fred Hutch News Service
Patients in a clinical trial, including Dr. Curtis Mack, had lower rates of graft-vs.-host disease when researchers filtered stem cells before transplant, scientists reported Monday.
(RSS feeds are best viewed in browsers other than Chrome)
Editor's Picks
Six misconceptions about colorectal cancer
Luke Timmerman to scale Mount Everest for Fred Hutch research
A message from Dr. Gary Gilliland about cancer research in 2018
GIVE NOW &
SAVE LIVES
Story Archive
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
Publications
Magazine Archive
Back issues of Hutch Magazine
Financial Reporting
Fiscal highlights & Annual Reports
Science Spotlight
Monthly review of Center-authored papers
Fred Hutch News
Get updates via email.
